4//SEC Filing
Ryali Sriram 4
Accession 0001567619-22-006948
CIK 0001305253other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 9:22 PM ET
Size
4.8 KB
Accession
0001567619-22-006948
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-03-14$5.60/sh−2,266$12,683→ 41,566 total
Footnotes (1)
- [F1]These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 14, 2022 for 5,417 shares.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001762893
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 9:22 PM ET
- Size
- 4.8 KB